All across the Tennessee Valley on Saturday, families and organizations were raising awareness for ALS, also commonly known as Lou Gehrig’s disease. The disease attacks the nerve cells responsible for controlling muscle movement.
A walk to support those living with amyotrophic lateral sclerosis, more commonly known as ALS, is happening this weekend.
One of those participating this year is Tim Ritter, along with his team “Ritter’s Recruits.”
Ritter is a veteran who served our nation for 26 years in both the Army and the Navy. He was medically retired at the rank of commander after being diagnosed with ALS in 2015.
The Dormie Network Foundation supports The ALS Association’s fundraising efforts by donating auction packages to be used at various National Signature Events such as golf tournaments, galas, and online auction fundraisers.
The combination drug of sodium phenylbutyrate–taurursodiol has been shown to functional decline in patients with amyotrophic lateral sclerosis compared with placebo in the phase 2/3 CENTAUR trial.
The organization called attention to unintended harms of the current Medicare benefit structure and the need for the Center for Medicare & Medicaid Services to be more “patient-focused” in its assessments.
Paul Kirsch got vaccinated against COVID-19 as soon as he became eligible, telling his wife it was a “must.”
Kirsch had been diagnosed with amyotrophic lateral sclerosis (ALS) in 2018 and wanted to live as long as he could, even as his life became restricted by the degenerative disease taking over his body, said his wife, Emily Kirsch.
Although we each experience a different journey with ALS, I believe we all can relate to first-year mistakes. Following are three of mine and how I conquered them.
On September 15, Amylyx Pharmaceuticals announced that its bid to submit a new drug application (NDA) for its amyotrophic lateral sclerosis (ALS) investigational asset AMX0035, using data from the Phase II CENTAUR trial, has been permitted following recent discussions with the FDA.